Prompt-based multimodal representation learning for drug repurposing.
- Publisher:
- Oxford University Press (OUP)
- Publication Type:
- Journal Article
- Citation:
- Brief Bioinform, 2025, 26, (6), pp. bbaf636
- Issue Date:
- 2025-11-01
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
| Field | Value | Language |
|---|---|---|
| dc.contributor.author | Liu, J | |
| dc.contributor.author | U, K | |
| dc.contributor.author | Rana, D | |
| dc.contributor.author | Meixuan Zhang, S | |
| dc.contributor.author | Yu, J | |
| dc.contributor.author | Yang, S | |
| dc.contributor.author | Jin, B | |
| dc.contributor.author | Wang, X | |
| dc.contributor.author | Yang, Z | |
| dc.contributor.author | Tang, H | |
| dc.contributor.author | Zhao, J | |
| dc.date.accessioned | 2026-06-05T02:02:28Z | |
| dc.date.available | 2025-10-23 | |
| dc.date.available | 2026-06-05T02:02:28Z | |
| dc.date.issued | 2025-11-01 | |
| dc.identifier.citation | Brief Bioinform, 2025, 26, (6), pp. bbaf636 | |
| dc.identifier.issn | 1467-5463 | |
| dc.identifier.issn | 1477-4054 | |
| dc.identifier.uri | http://hdl.handle.net/10453/195238 | |
| dc.description.abstract | Drug repurposing significantly reduces development costs and shortens research cycles, making it a critical strategy in drug discovery. An emerging class of drug repurposing approaches applies deep learning to structural data. However, these methods often depend on static representations of molecular and protein structures, which may not fully capture the dynamic character of compound-protein interactions. To address these challenges and enhance the accuracy of compound-protein interaction predictions, we introduce an innovative prompt-based multimodal representation learning framework that dynamically encodes task-specific contextual information for drug repurposing. Specifically, the framework includes a dynamic prompt generation module that adaptively creates receptor-specific prompts and a prompt calibration module for effective multimodal feature integration and optimization. When applied to identifying FDA-approved drug candidates targeting G-protein-coupled receptors, our method achieved a 7.4% improvement in mean absolute error compared with state-of-the-art methods, with up to a 25.1% improvement for specific target-of-interest. By demonstrating potential in repurposing non-opioid treatments without the risk of addiction for safe pain management, our method has the capacity to advance drug discovery and meet a wide range of therapeutic needs. | |
| dc.format | ||
| dc.language | eng | |
| dc.publisher | Oxford University Press (OUP) | |
| dc.relation.ispartof | Brief Bioinform | |
| dc.relation.isbasedon | 10.1093/bib/bbaf636 | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | 0601 Biochemistry and Cell Biology, 0802 Computation Theory and Mathematics, 0899 Other Information and Computing Sciences | |
| dc.subject.classification | Bioinformatics | |
| dc.subject.classification | 3101 Biochemistry and cell biology | |
| dc.subject.classification | 3102 Bioinformatics and computational biology | |
| dc.subject.classification | 3105 Genetics | |
| dc.subject.mesh | Drug Repositioning | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Drug Discovery | |
| dc.subject.mesh | Deep Learning | |
| dc.subject.mesh | Machine Learning | |
| dc.subject.mesh | Receptors, G-Protein-Coupled | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Receptors, G-Protein-Coupled | |
| dc.subject.mesh | Drug Discovery | |
| dc.subject.mesh | Drug Repositioning | |
| dc.subject.mesh | Machine Learning | |
| dc.subject.mesh | Deep Learning | |
| dc.subject.mesh | Drug Repositioning | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Drug Discovery | |
| dc.subject.mesh | Deep Learning | |
| dc.subject.mesh | Machine Learning | |
| dc.subject.mesh | Receptors, G-Protein-Coupled | |
| dc.title | Prompt-based multimodal representation learning for drug repurposing. | |
| dc.type | Journal Article | |
| utslib.citation.volume | 26 | |
| utslib.location.activity | England | |
| utslib.for | 0601 Biochemistry and Cell Biology | |
| utslib.for | 0802 Computation Theory and Mathematics | |
| utslib.for | 0899 Other Information and Computing Sciences | |
| pubs.organisational-group | University of Technology Sydney | |
| pubs.organisational-group | University of Technology Sydney/Faculty of Engineering and Information Technology | |
| utslib.copyright.status | open_access | * |
| dc.rights.license | This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0/ | |
| dc.date.updated | 2026-06-05T02:02:24Z | |
| pubs.issue | 6 | |
| pubs.publication-status | Published | |
| pubs.volume | 26 | |
| utslib.citation.issue | 6 |
Abstract:
Drug repurposing significantly reduces development costs and shortens research cycles, making it a critical strategy in drug discovery. An emerging class of drug repurposing approaches applies deep learning to structural data. However, these methods often depend on static representations of molecular and protein structures, which may not fully capture the dynamic character of compound-protein interactions. To address these challenges and enhance the accuracy of compound-protein interaction predictions, we introduce an innovative prompt-based multimodal representation learning framework that dynamically encodes task-specific contextual information for drug repurposing. Specifically, the framework includes a dynamic prompt generation module that adaptively creates receptor-specific prompts and a prompt calibration module for effective multimodal feature integration and optimization. When applied to identifying FDA-approved drug candidates targeting G-protein-coupled receptors, our method achieved a 7.4% improvement in mean absolute error compared with state-of-the-art methods, with up to a 25.1% improvement for specific target-of-interest. By demonstrating potential in repurposing non-opioid treatments without the risk of addiction for safe pain management, our method has the capacity to advance drug discovery and meet a wide range of therapeutic needs.
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph
